About the Authors

Jose I. Bernardino

Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing

jose.bernardino@salud.madrid.org

Affiliation Department of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain

Amanda Mocroft

Roles Formal analysis, Methodology, Writing – review & editing

Affiliation University College London, London, United Kingdom

Cedrick Wallet

Roles Data curation, Methodology, Project administration, Writing – review & editing

Affiliation University of Bordeaux INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France

Stéphane de Wit

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation CHU Saint Pierre, Université Libre de Bruxeles, Brussels, Belgium

Christine Katlama

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation Hôpital Pitié Salpétrière, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France

Peter Reiss

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation Department of Global Health and Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Patrick W. Mallon

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation School of Medicine, University College Dublin, Dublin, Ireland

Laura Richert

Roles Methodology, Writing – review & editing

Affiliation University of Bordeaux INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France

Jean-Michel Molina

Roles Investigation, Writing – review & editing

Affiliation Hôpital Saint-Louis, University of Paris Diderot, Paris, INSERM U941, France

Hernando Knobel

Roles Investigation, Writing – review & editing

Affiliation Department of Infectious Diseases, Hospital del Mar, Universidad Autónoma de Barcelona, Spain

Philippe Morlat

Roles Investigation, Writing – review & editing

Affiliation Service de Medicine Interne et Maladies Infectieuses, CHU Bordeaux, Université de Bordeaux, Inserm U 1219, Bourdeaux, France

Abdel Babiker

Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

Affiliation MRC Clinical Trials Unit at UCL, London, United Kingdom

Anton Pozniac

Roles Investigation, Writing – review & editing

Affiliation Chelsea and Westminster hospital NHS Foundation Trust, London, United Kingdom

Francois Raffi

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation Department of infectious diseases, CHU de Nantes and CIC 1413, INSERM, Nantes, France

Jose R. Arribas

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation Department of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain

the NEAT001/ANRS143 Trial Study Group

Membership of the NEAT001/ANRS143 Trial Study Group is provided in the Acknowledgments

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: JIB reports grants from Ministerio de Sanidad, Servicio Sociales e Iguadad (TRA-054), during the conduct of the study; personal fees from Gilead Sciences, ViiV Healthcare, MSD, and Janssen. JRA reports grants and personal fees from Gilead, personal fees from Janssen, ViiV and Merck. CW reports grants from European Commission and Inserm-ANRS, non-financial support from Gilead, Janssen Pharmaceuticals and Merck during the conduct of the study; grants from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, MSD, Pfizer, Roche, Tibotec, and ViiV Healthcare to the author's institution outside the submitted work. LR reports grants from European Commission and Inserm-ANRS, non-financial support from Gilead, Janssen Pharmaceuticals and Merck during the conduct of the study; grants from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, MSD, Pfizer, Roche, Tibotec, and ViiV Healthcare to the author's institution, outside the submitted work. AB reports grants from EU Fifth Framework Programme (though NEAT network of excellence), grants from ANRS, France, grants from Medical Research Council, UK, during the conduct of the study. AM reports personal fees from ViiV, Pfizer, BI, Gilead, Merck, BMS and Wragge LLC, outside the submitted work. JMM reports grants from Merck and Gilead, personal fees from Merck, Gilead,BMS, ViiV, TEVA, and Janssen outside the submitted work. CK reports having received consultancy fees and/or travel grants from Merck, Gilead, BMS, ViiV, BMS, and Janssen. PWM reports grants and personal fees from Gilead Sciences, ViiV Healthcare, Janssen Cilag, and MSD outside the submitted work. PM reports personal fees from Gilead and MSD Board, personal fees from ViiV health care consultancy, outside the submitted work. PR reports grants from Gilead, ViiV Healthcare, Janssen Pharmaceutica, Bristol Myers Squibb, and Merck & Co. FR received research funding or honoraria from or consulted for Gilead Sciences, Janssen Pharmaceuticals, MSD, and Merck. AP reports grants from SSAT, and NEAT, during the conduct of the study; personal fees from Janssen, Gilead, Merck, outside the submitted work; and was vice chair of NEAT and was on BHIVA and EACS ART guidelines committees at time of study. All other authors declare no conflicts of interest. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.